PubMed=16464451; DOI=10.1016/j.expneurol.2005.12.011
Kenneth Pollock, Paul Stroemer, Sara Patel, Lara Stevanato, Andrew D. Hope, Erik A. Miljan, Zi-Ping Dong, Helen Hodges, Jack Price, John D. Sinden;
A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke.
Exp. Neurol. 199:143-155(2006)

PubMed=19343502; DOI=10.1007/s10529-009-9989-1
Robert James Thomas, Andrew D. Hope, Paul C. Hourd, Marc-Olivier Baradez, Erik A. Miljan, John D. Sinden, David J. Williams;
Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line.
Biotechnol. Lett. 31:1167-1172(2009)

PubMed=19633272; DOI=10.1177/1545968309335978
Paul Stroemer, Sara Patel, Andrew D. Hope, Cathy Oliveira, Kenneth Pollock, John D. Sinden;
The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion.
Neurorehabil. Neural Repair 23:895-909(2009)

Patent=US7666672
John D. Sinden, Kenneth Pollock, Paul Stroemer;
Cell lines.
Patent number US7666672, 23-Feb-2010

PubMed=32374064; DOI=10.1002/stem.3191; PMCID=PMC7496241
Yongwoo Yoon, Hyun Sook Kim, Iksoo Jeon, Jeong-Eun Noh, Hyun Jung Park, Suji Lee, In-Hyun Park, Lara Stevanato, Caroline Hicks, Randolph Corteling, Roger Alistair Barker ...Show all 13 authors... , John D. Sinden, Jihwan Song; Show fewer authors
Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease.
Stem Cells 38:936-947(2020)